Insider

Andrew D Dickinson

Chief Financial Officer · Gilead Sciences, Inc. (GILD)

sold: $1,418,940

DateTradeSharesAvg. priceValueFiling
November 16, 2026Sale 10b5-1 plan notice filed3,000$171.47$514,410SEC
October 15, 2026Sale 10b5-1 plan notice filed3,000$156.22$468,660SEC
September 15, 2026Sale 10b5-1 plan notice filed3,000$145.29$435,870SEC

Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.